Arbutus Biopharma Corporation (ABUS) Social Stream

Arbutus Biopharma Corporation (ABUS): $2.81

-0.20 (-6.64%)

POWR Rating

Component Grades













Add ABUS to Watchlist
Sign Up

Industry: Biotech


of 462

in industry

Arbutus Biopharma Corp (ABUS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Arbutus Biopharma Corp.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $9 $4 $6.1 $3.82 59.69%
5 $9 $4 $6 $3.82 57.07%

The Trend in the Analyst Price Target

ABUS's average price target has moved down $0.01 over the prior 33 weeks.

Over the past 18 months, ABUS's average upside potential has been 82.87%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-02 5 9 4 6.1 4.31 41.53%
2020-06-09 5 10 4 5.8 NA NA%

ABUS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.8 3 0 2 0 0 5

The Trend in the Broker Recommendations

ABUS's average broker recommendation rating improved by 0.6 over the prior 61 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ABUS has a greater average analyst price target than 9.28% of all US stocks.
  • The variance in analysts' estimates of ABUS is lower than -79.1% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of ABUS is higher than 141.06% of all US stocks.
  • ABUS has a higher number of analysts covering the stock than 66.46% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Arbutus Biopharma Corp are MOLN, MYOV and VERV.

Is ABUS a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8669 seconds.